A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: The Belgrade Atrial Fibrillation Study

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 4744-4749

  Potpara, Tatjana S ^a,b   Polovina, Marija M ^b   Marinkovic, Jelena M ^a   Lip, Gregory Y H ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Ablation of atrial fibrillation; Asymptomatic atrial fibrillation; Atrial fibrillation; First diagnosed atrial fibrillation; Progression of atrial fibrillation; Stroke risk factors

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DILTIAZEM; DISOPYRAMIDE; FLECAINIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ADULT; AGE DISTRIBUTION; ARTICLE; CHADS2 SCORE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE REGISTRY; FEMALE; FOLLOW UP; GENDER; HEART ATRIUM FIBRILLATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; SYMPTOMATOLOGY; THROMBOSIS;

ABLATION OF ATRIAL FIBRILLATION; ASYMPTOMATIC ATRIAL FIBRILLATION; ATRIAL FIBRILLATION; FIRST-DIAGNOSED ATRIAL FIBRILLATION; PROGRESSION OF ATRIAL FIBRILLATION; STROKE RISK FACTORS;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SERBIA; STROKE; SURVIVAL RATE; TIME FACTORS;

EID: 84886425498     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.234     Document Type: Article

References (25)

1. S. Lévy, M. Maarek, and P. Coumel Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists Circulation 99 1999 3028 3035
2. I. Savelieva, M. Paquette, P. Dorian, B. Lüderitz, and A.J. Camm Quality of life in patients with silent atrial fibrillation Heart 85 2001 216 217
3. V. Frykman, M. Frick, M. Jensen-Urstad, J. Ostergren, and M. Rosenqvist Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics J Intern Med 250 2001 390 397
4. G.C. Flaker, K. Belew, and K. Beckman Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am Heart J 149 2005 657 663
5. R.L. Page, T.W. Tilsch, and S.J. Connolly Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide Circulation 107 2003 1141 1145
6. R.L. Page Beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias? J Am Coll Cardiol 36 2000 147 150
7. C.D. Furberg, B.M. Psaty, T.A. Manolio, J.M. Gardin, V.E. Smith, and P.M. Rautahariu The prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 1994 236 241
8. J. Liao, Z. Khalid, C. Scallan, C. Morillo, and M. O'Donnell Noninvasive cardiac monitoring for detection of paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review Stroke 38 2007 2935 2940
9. T.V. Glotzer, A.S. Hellkamp, and J. Zimmerman Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the Mode Selection Trial (MOST) Circulation 107 2003 1614 1619
10. T.V. Glotzer, E.G. Daoud, and D.G. Wyse The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
11. J.S. Healey, S.J. Connolly, and M.R. Gold Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
12. C.R. Kerr, J. Boone, and S.J. Connolly The Canadian registry of atrial fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation Am J Cardiol 82 1998 82N 85N
13. J.A. Camm, P. Kirchof, and G.Y.H. Lip Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
14. S. Dublin, N.L. Glazer, and N.L. Smith Diabetes mellitus, glycemic control, and risk of atrial fibrillation J Gen Intern Med 25 2010 853 858
15. M.R. Movahed, M. Hashemzadeh, and M.M. Jamal Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease Int J Cardiol 105 2005 315 318
16. B. Stratmann, and D. Tschöpe Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy Herz 37 2012 258 263
17. I. Nault, S. Miyazaki, and A. Forclaz Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation Eur Heart J 31 2010 1046 1057
18. I.C. Van Gelder, L.M. Haegeli, and A. Brandes Rationale and current perspective for early rhythm control therapy in atrial fibrillation Europace 13 2011 1517 1525
19. G.Y. Lip Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score = 1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice Thromb Haemost 103 2010 683 685
20. C. Keogh, E. Wallace, C. Dillon, B.D. Dimitrov, and T. Fahey Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke. A systematic review and meta-analysis Thromb Haemost 106 2011 528 538
21. S. Agarwal, R. Hachamovitch, and V. Menon Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation. A meta-analysis Arch Intern Med 172 2012 623 631
22. J.B. Olesen, G.Y. Lip, and J. Lindhardsen Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study Thromb Haemost 106 2011 739 749
23. J. Ip, A.L. Waldo, and G.Y. Lip Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study Am Heart J 158 2009 364 370.e1
24. E. Doufekias, A.Z. Segal, and J.R. Kizer Cardiogenic and aortogenic brain embolism J Am Coll Cardiol 51 2008 1049 1059
25. E. von Elm, D.G. Altman, and M. Egger The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Lancet 370 2007 1453 1457